Vertex Pharmaceuticals Incorporated
Market Cap
$119.51B
P/E Ratio
49.08
EPS
$9.47
Dividend Yield
0.00%
52-Week Range
$290.87 — $488.98
Volume
154
Avg Volume
2.91K
Beta
0.32
P/E (TTM)
49.08
Forward P/E
23.71
PEG Ratio
3.86
P/S (TTM)
10.08
P/B (TTM)
6.50
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
0.23%
ROA (TTM)
0.15%
ROIC
—
Gross Margin
0.86%
Operating Margin
0.35%
Net Margin
—
Debt/Equity
0.21
Current Ratio
2.90
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+2.46%
EPS Growth (5Y)
+1.53%
Sales Growth (3Y)
+0.10%
Sales Growth (5Y)
+0.14%
EPS Est (This Year)
$19.61
EPS Est (Next Year)
$22.97
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$26.04
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
-21571
Outstanding Shares
257.00M
Float
252.86M
Free Float %
98.39%
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
US
Exchange
LSE
IPO Date
2014-11-10
Employees
6100
CEO
Reshma Kewalramani
Index Membership
—
Website
https://www.vrtx.com
Vertex Pharmaceuticals Incorporated (0QZU.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $119.51B, a P/E ratio of 49.08, 0QZU.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0QZU.L against other stocks using dozens of fundamental and technical filters.
Vertex Pharmaceuticals Incorporated (0QZU.L) has a trailing twelve-month (TTM) P/E ratio of 49.08. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Vertex Pharmaceuticals Incorporated (0QZU.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Vertex Pharmaceuticals Incorporated (0QZU.L) has a market capitalization of $119.51 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.